Orion Corporation B
Orion Corporation B
0,35 %
31,45 EUR
0,11
Kurs
31,45
Hög
31,73
Förändring
0,35 %
Låg
31,38
Uppdaterad
15:34:07
Öppen
31,42
Factsheet for Orion Corporation B
Company Profile
Description
Orion Oyj is a specialty and generic drug manufacturing company. Orion maintains two segments, which are Pharmaceuticals business and Diagnostics business. The Pharmaceuticals business develops, manufactures and markets pharmaceuticals and active pharmaceutical ingredients. The Diagnostics business develops, manufactures, and markets diagnostic tests. Most of the company's sales are generated by the pharmaceuticals segment. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
Key Stats
Website: http://www.orion.fi
Headquarter country: Finland
Employees: 3 519
Market Cap (at close 20-06-2019): EUR 4B
Fiscal Year Ends: december
Stats

Stats 2018 2017 2016 2015 2014
Price/Earnings 20,90 19,90 24,70 21,50 17,70
Forward Price/Earnings 21,80 19,40
Price/Free Cash Flow 25,70 25,00 29,40 21,50 14,40
Return on Assets 30,00 21,30 23,60 20,30 21,30
Return on Equity 45,50 34,20 40,30 37,50 41,10
Return on Invested Capital 38,00 28,20 32,10 27,70 28,30
Dividend


Dividend/Share:1,50
Ex. Dividend Date:2018-12-31
Trailing Dividend Yield:4,79
Payout Ratio:113,64
Date Currency Amount
2019-03-31 EUR 1,50
2018-03-31 EUR 1,45
2017-03-31 EUR 1,35
2016-03-31 EUR 1,30
2015-03-31 EUR 1,30
2014-03-31 EUR 1,25
Income Statement

Revenue 2018 2017 2016 2015 2014
Total Revenue 977,40 1 084,70 1 073,50 1 015,60 1 015,30
Gross Profit 0,59 0,64 0,65 0,61 0,61
Gross Margin % 60,32% 59,37% 60,72% 60,04% 60,44%
Operating Expenses 2018 2017 2016 2015 2014
EBITDA 295,00 333,00 356,00 309,00 313,00
Net income 330,00 226,00 249,00 208,00 211,00
Basic Earnings Per Share 2,35 1,61 1,77 1,48 1,50
Operating Income 0,25 0,29 0,29 0,27 0,27
Operating Margin % 25,68% 26,99% 27,21% 26,36% 26,75%
Cash Flow

Cash Flow 2018 2017 2016 2015 2014
Operating Cash Flow 231,00 228,00 249,00 255,00 297,00
Capital Expenditures -67,00 -77,00 -48,00 -43,00 -56,00
Free Cash Flow 164,00 152,00 201,00 212,00 240,00
Balance Sheet

Assets 2018-12-31 2017-12-31 2016-12-31 2015-12-31 2014-12-31
Current Assets 728,20 620,70 691,50 674,10 652,40 629,90
Long Term Assets 418,50 434,70 371,50 373,30 349,10 349,20
Total Assets 1 146,70 1 055,50 1 062,90 1 047,40 1 001,50 979,00
Liabilities 2018-12-31 2017-12-31 2016-12-31 2015-12-31 2014-12-31
Total Current Liabilities 313,80 179,70 230,60 233,30 214,80 197,50
Long Term Liabilities 196,10 190,80 219,20
Total Liabilities 375,80 421,50 452,50
Equity 2018-12-31 2017-12-31 2016-12-31 2015-12-31 2014-12-31
Retained Earnings 678,00 584,60 546,60 495,30 416,30 419,60
Treasury Stock
Total Stockholder Equity 773,10 679,70 641,10 594,90 514,90 513,90
Net Tangible Assets 709,50 626,80 587,20 537,20 450,90 443,10